Discover 3,132 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,132
A Study of MF101 in Postmenopausal Women
for
Hot Flushes, Vasomotor Symptoms
Location: Lake Jackson TX, Austin TX, Dallas TX, Jackson TN,
Sponsor: Bionovo
Sex: Female
Age: 40 - 65
Code: NCT00906308
Phase 3, Recruiting
Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers
for
Chronic Diabetic Foot Ulcers
Location: Galveston TX, San Antonio TX, Akron OH,
Sponsor: Tissue Regeneration Technologies
Sex: All
Age: 18+
Code: NCT00366132
Phase 2, Recruiting
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis
for
Osteoarthritis, Knee
Location: Cleveland TX, Scottsdale AZ, Beverly Hills CA,
Sponsor: R3 Medical Research
Sex: All
Age: 30+
Code: NCT06608134
Early Phase 1, Recruiting
New
A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy
for
IgA Nephropathy (IgAN)
Location: Katy TX, Atlanta GA, Arvada CO, Lauderdale Lakes FL
Sponsor: Jade Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07902817
Phase 3, Recruiting
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
for
Alopecia Areata
Location: Webster TX, Pflugerville TX, San Antonio TX,
Sponsor: ASLAN Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05865041
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
for
Pruritus
Location: Sugar Land TX, New Orleans LA, Macon GA, Belleair FL,
Sponsor: Sanofi
Sex: All
Age: 18 - 70+
Code: NCT05263206
Phase 3, Recruiting
New
A Study to Assess the Efficacy and Safety of THB335 in Adults With Chronic Spontaneous Urticaria (CSU)
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Bellaire TX, The Woodlands TX, Austin TX, Round Rock TX,
Sponsor: ADARx Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT06990269
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
for
Focal Segmental Glomerulosclerosis,
Location: Houston TX, Dallas TX, Birmingham AL, El Paso TX,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT06500702
Phase 2, Recruiting
New
Low-Dose Atropine Eye Drops for Excessive Tearing (Epiphora)
for
Epiphora
Location: Houston TX, Mesquite TX
Sponsor: Rehan Ahmed
Sex: All
Age: 18+
Code: NCT07816224
Phase 2, Recruiting
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
for
Sickle Cell Disease
Location: Houston TX, New Orleans LA, Little Rock AR,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 12+
Code: NCT06612268
Phase 3, Recruiting
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Houston TX, Beaumont TX, Austin TX, New Orleans LA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06290141
Phase 3, Recruiting
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists